Identification of candidate methylation-responsive genes in ovarian cancer

Thumbnail Image
Files
2007_mcdonald_BMC_001.pdf (424.53 KB)
Author(s)
Menendez, Laura
Walker, L. DeEtte
Matyunina, Lilya V.
Dickerson, Erin B.
Bowen, Nathan J.
Benigno, Benedict B.
Advisor(s)
Editor(s)
Associated Organization(s)
Organizational Unit
Organizational Unit
School of Biological Sciences
School established in 2016 with the merger of the Schools of Applied Physiology and Biology
Series
Collections
Research Publications
Supplementary to:
Permanent Link
http://hdl.handle.net/1853/32513
Abstract
Background: Aberrant methylation of gene promoter regions has been linked to changes in gene expression in cancer development and progression. Genes associated with CpG islands (CGIs) are especially prone to methylation, but not all CGI-associated genes display changes in methylation patterns in cancers. Results: In order to identify genes subject to regulation by methylation, we conducted gene expression profile analyses of an ovarian cancer cell line (OVCAR-3) before and after treatment with the demethylating agent 5-aza-deoxycytidine (5-aza-dC). An overlapping subset of these genes was found to display significant differences in gene expression between normal ovarian surface epithelial cells and malignant cells isolated from ovarian carcinomas. While 40% of all human genes are associated with CGIs, > 94% of the overlapping subset of genes is associated with CGIs. The predicted change in methylation status of genes randomly selected from the overlapping subset was experimentally verified. Conclusion: We conclude that correlating genes that are upregulated in response to 5-aza-dC treatment of cancer cell lines with genes that are down-regulated in cancer cells may be a useful method to identify genes experiencing epigenetic-mediated changes in expression over cancer development.
Sponsor
Date
2007-01-25
Extent
Resource Type
Text
Resource Subtype
Article
Rights Statement
Rights URI